30191
Angiofibromas, trichoepithelioma, epidermal naevi, xanthelasma, pyogenic…
Therapeutic procedures · Group T8 — Surgical operations
Schedule fee
$76.00
| Benefit | Amount | Gap to fee |
|---|---|---|
| 85% | $64.60 | $11.40 |
| 75% | $57.00 | $19.00 |
Benefit amounts as published in the schedule, not recalculated.
Fee current from 1 Jul 2026.
Descriptor · the legislated text
Angiofibromas, trichoepithelioma, epidermal naevi, xanthelasma, pyogenic granuloma, genital angiokeratomas, hereditary haemorrhagic telangiectasia and other severely disfiguring or recurrently bleeding tumours (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), treatment of, with carbon dioxide/erbium or other appropriate laser (or curettage and fine point diathermy for pyogenic granuloma only), if confirmed by the opinion of a specialist in the specialty of dermatology, one or more lesions.
Descriptor current from 1 Nov 2018.
| Item number | 30191 |
|---|---|
| Category | 3 — Therapeutic procedures |
| Group | T8 — Surgical operations |
| Subheading | — |
| Item type | S |
| Fee type | N |
| In schedule since | 1 Nov 2018 |
| Fee current from | 1 Jul 2026 |
| GP scope | Yes · tier 2 |
Official page
As at 1 Aug 2026